Throat lozenges could be contributing to antimicrobial resistance

  13 April 2019

The inappropriate use of OTC sore throat medications that contain antibiotics could thus be preventing hindering the WHO’s plans to tackle AMR in order to “ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines.

Further reading: PharmaFile
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!